Avian influenza, commonly referred to as bird flu, continues to circulate among bird populations in Australia, raising concerns about potential human infection. As of early 2026, no confirmed cases of the current strain, H5N1 variant 2.3.4.4b, have been detected in humans within the country. However, the increasing presence of the virus in both migratory and native bird species has prompted heightened vigilance among public health officials. Despite the absence of human infections thus far, experts caution that the risk, though assessed as low, warrants continued monitoring. The emergence of the 2.3.4.4b strain since 2020 has led to significant impacts on global bird populations, resulting in mass mortality events across multiple regions. These incidents have included outbreaks among poultry, dairy cattle, and marine mammals. In Australia, initial reports indicated the presence of the virus in migratory birds, followed by its detection in local wild bird populations. While official statistics focus on reporting individual events rather than specific numbers of affected birds, at least one mass mortality incident has been documented. Human infection with bird flu is possible, particularly through direct contact with infected birds. Globally, the World Health Organization has recorded over 1,000 cases of H5N1 bird flu in humans since 2003, with nearly half of these cases resulting in fatalities. This year alone, seven instances of human infection have been reported in countries such as Cambodia, Bangladesh, and India, with two deaths attributed to the virus. However, the 2.3.4.4b strain appears to cause milder symptoms compared to previous variants, although exceptions exist, including two fatalities linked to this strain in the United States. Australia’s national health authority, the Australian Centre for Disease Control, maintains that the risk of human infection from the current strain remains low. Nevertheless, individuals working closely with birds, such as wildlife carers and veterinary professionals, are considered high-risk groups. Public health officials are also keeping a watchful eye on other potentially vulnerable sectors, such as poultry industry workers, in anticipation of any changes in the outbreak dynamics. Symptoms of bird flu in humans are generally similar to those of seasonal influenza, encompassing fever, cough, and runny nose. Additional signs may include gastrointestinal issues like nausea and diarrhea, along with conjunctivitis, which is less frequently observed in typical seasonal flu cases. Severe complications are relatively uncommon with the 2.3.4.4b strain, though more serious outcomes have been noted in some instances involving different H5N1 variants. Diagnosis of bird flu requires specific laboratory testing, which differs from standard flu tests that cannot differentiate between seasonal and avian influenza. Healthcare providers must be informed of a patient’s potential exposure to infected birds to ensure appropriate diagnostic procedures are initiated. Individuals experiencing flu-like symptoms and belonging to high-risk categories are advised to consult their physician promptly, ideally after notifying them in advance and wearing a protective mask upon arrival for testing. Public health strategies emphasize prevention and surveillance as key measures to mitigate the spread of bird flu. Authorities recommend avoiding direct contact with sick or deceased birds, practicing thorough hand hygiene, and adhering to biosecurity protocols in areas where the virus is prevalent. Continued research into the behavior of the 2.3.4.4b strain will inform future responses to potential shifts in its transmissibility or virulence.
★
Keep the news honest.
ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €4/month.
Become a Supporter